SG/PUT/INTUITIVE SURGICAL/350/0.1/21.03.25 Share Price

Warrant

DE000SU6QPB2

Market Closed - Bid/Ask 19:36:30 01/07/2024 BST After market 20:33:27
1.4 EUR +8.53% Intraday chart for SG/PUT/INTUITIVE SURGICAL/350/0.1/21.03.25 1.38 -1.43%
Current month+6.20%
1 month-35.68%
Date Price Change
01/07/24 1.4 +8.53%
28/06/24 1.29 +2.38%
27/06/24 1.26 -0.79%
26/06/24 1.27 -0.78%
25/06/24 1.28 -9.86%

Real-time Boerse Frankfurt Warrants

Last update July 01, 2024 at 07:36 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying INTUITIVE SURGICAL, INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SU6QPB
ISINDE000SU6QPB2
Date issued 08/01/2024
Strike 350 $
Maturity 21/03/2025 (263 Days)
Parity 10 : 1
Emission price 5.31
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 5.25
Lowest since issue 1.19
Delta-0.17x
Omega 4.897
Premium22.87x
Gearing28.47x
Moneyness 0.8064
Difference Strike -86.74 $
Difference Strike %-24.78%
Spread 0.02
Spread %1.40%
Theoretical value 1.400
Implied Volatility 38.39 %
Total Loss Probability 73.61 %
Intrinsic value 0.000000
Present value 1.400
Break even 334.97 €
Theta-0.04x
Vega0.09x
Rho-0.06x

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
444.8 USD
Average target price
426.5 USD
Spread / Average Target
-4.13%
Consensus